Record # |
Select Document Category |
Anticipated publication year |
Publication year |
Source (e.g. developer/organization) |
Acronym (e.g. ISO, IEC) |
Identifier (e.g. document designation number) |
Title of document |
URL Link |
Scope/description |
Keywords |
Type of Document |
Issue area(s) this applies to |
Primary category that this applies to |
Any additional categories this applies to |
Goal or need for this document |
Intended stakeholders |
Is it being implemented on a national or subnational level? If so, how and why? |
How is this document being used on the market? |
Submitter's name |
Email address |
Submitter's company/organization |
Additional comments |
Contact for additional comments and inquiries |
(This field is for ANSI use only) |
login |
group |
Last modified |
107
|
Published Document
|
|
2009
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-1
|
Analysis of Hemolytic Properties of Nanoparticles
|
http://ncl.cancer.gov/NCL_Method_ITA-1.pdf
|
The hemolytic potential of all intravenously administered pharmaceuticals must be evaluated....
|
in vivo, hemolytic potential, nanoparticles
|
|
|
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-10 |
108
|
Published Document
|
|
2009
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-1
|
Analysis of Hemolytic Properties of Nanoparticles
|
http://ncl.cancer.gov/NCL_Method_ITA-1.pdf
|
The hemolytic potential of all intravenously administered pharmaceuticals must be evaluated....
|
in vivo, hemolytic potential, nanoparticles
|
|
|
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-10 |
109
|
Published Document
|
|
2009
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-2
|
Analysis of Platelet Aggregation
|
http://ncl.cancer.gov/NCL_Method_ITA-2.pdf
|
This document describes a procedure for analysis of platelet aggregation
(1-6). Platelets are...
|
thrombocyte, megakaryocyte, Platelets
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-10 |
110
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-4
|
NCL Method ITA-4 Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE
|
http://ncl.cancer.gov/NCL_Method_ITA-4.pdf
|
Proteins bind the surfaces of nanoparticles, and biological materials in general, immediately...
|
nanoparticles, protein binding, phagocytic cells
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-10 |
111
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-5.1
|
Qualitative Analysis of Tota l Complement Activation by Western Blot
|
http://ncl.cancer.gov/NCL_Method_ITA-5.1.pdf
|
This document describes a protocol for qualitative determination of total complement
activation...
|
Western blot, lectin
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
112
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-5.2
|
Quantitative Analysis of Complement Activation
|
http://ncl.cancer.gov/NCL_Method_ITA-5.2.pdf
|
This document describes a protocol for quantitative determination of complement activation by an...
|
EIA
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
113
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-12
|
Coagulation Assays
|
http://ncl.cancer.gov/NCL_Method_ITA-12.pdf
|
This document describes a protocol for assessing the effect a nanoparticle formulation may have...
|
APTT, TT, Coagulation
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
114
|
Published Document
|
|
2009
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-3
|
Mouse Granulocyte-Macrophage Colony-Forming Unit Assay
|
http://ncl.cancer.gov/NCL_Method_ITA-3.pdf
|
Myelosuppression is a common dose limiting toxicity of cytotoxic oncology drugs. Nanoparticles...
|
BM, granulocyte macrophagecolony, Myelosuppression
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
115
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-6
|
Leukocyte Proliferation Assay
|
http://ncl.cancer.gov/NCL_Method_ITA-6.pdf
|
This document describes a protocol for assessing the effect of a nanoparticle formulation on the...
|
PHA-M,lymphocytes
|
e. Specification
|
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
116
|
Published Document
|
|
2011
|
National Institute of Standards and Technology-Nanotechnology Characterization Laboratory
|
NCL
|
ITA-7
|
Detection of Nitric Oxide Producti on by the Macrophage Cell Line RAW264.7
|
http://ncl.cancer.gov/NCL_Method_ITA-7.pdf
|
This document describes a protocol for quantitative determination of nitrite (NO2-) a stable...
|
cytotoxicity, nitricoxide, NO 2, NO 3
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
117
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-8
|
Chemotaxis Assay
|
http://ncl.cancer.gov/NCL_Method_ITA-8.pdf
|
This document provides a protocol for rapid, quantitative measure of the chemoattractant capacity...
|
chemokines, chemoattractant capacity, prostaglandins, cytokines
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
118
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-9
|
Phagocytosis Assay
|
http://ncl.cancer.gov/NCL_Method_ITA-9.pdf
|
This document describes a protocol for evaluation of nanoparticle internalization by phagocytic...
|
phagolysosome
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
119
|
Published Document
|
|
2009
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-11
|
Measurement of Nanoparticle Effect s on Cytotoxic Activity of NK Cells by Label-Free RT-CES System
|
http://ncl.cancer.gov/NCL_Method_ITA-11.pdf
|
NK cells carry small granules in their cytoplasm which contain special proteins such as perforin...
|
perforin, NK, granzymes
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Energy e.g. Energy storage, energy efficiency
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
120
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-14
|
Analysis of Nanoparticle Effect s on Maturation of Monocyte Derived Dendritic Cells In Vitro
|
http://ncl.cancer.gov/NCL_Method_ITA-14.pdf
|
Dendritic cells (DC) are antigen-presenting cells. They play an important role in initiation and...
|
dendritic cells, cytotoxicity
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
121
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
ITA-17
|
In Vitro Induction of Leukoc yte Procoagulant Activity by Nanoparticles
|
http://ncl.cancer.gov/NCL_Method_ITA-17.pdf
|
Leukocyte procoagulant activity (PCA) is accepted as an important component in the onset of...
|
PCA, DIC, APL
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
122
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-3
|
Hep G2 Hepatocyte Glutathione Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-3.pdf
|
This protocol describes the analysis of human hepatocarcinoma cells (Hep G2) for reduced and...
|
glutathione, HepG2,
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
123
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-4
|
Hep G2 Hepatocyte Li pid Peroxidation Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-4.pdf
|
This protocol describes the analysis of human hepatocarcinoma cells (Hep G2) for lipid...
|
Hep G2, MDA
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
124
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-7
|
Hepatocyte Primary ROS Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-7.pdf
|
This protocol describes the testing of nanoparticle formulations for reactive oxygen species(ROS)...
|
hepatocytes, SD
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
A
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
125
|
Published Document
|
|
2010
|
LLC-PK1 Kidney Cytotoxicity Assay
|
|
GTA-1
|
LLC-PK1 Kidney Cytotoxicity Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-1.pdf
|
This protocol describes the cytotoxicity testing of nanoparticle formulations in porcine proximal...
|
LDH, MTT
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
126
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-2
|
Hep G2 Hepatocarcinoma Cytotoxicity Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-2.pdf
|
This protocol describes the cytotoxicity testing of nanoparticle formulations in human...
|
Hep g2, MTT, LDH
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
127
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-5
|
LLC-PK1 Kidney Cell Apoptosis Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-5.pdf
|
This protocol describes the monitoring of nanoparticle treated porcine renal proximal tubule...
|
LLC-PK1
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
128
|
Published Document
|
|
2010
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-6
|
HepG2 Hepatocarcinoma Apoptosis Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-6.pdf
|
This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells...
|
HepG2, caspase-3 activation
|
e. Specification
|
Measurement and Characterizations
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
129
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-14
|
Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay
|
http://ncl.cancer.gov/NCL_Method_GTA-14.pdf
|
This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells...
|
Hepg2, Caspase-3/7 activation
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
130
|
Published Document
|
|
2013
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-11
|
Autophagic Dysfunction Assay: Qualitative Analysis of MAP LC3 - I to LC3 - II C onversion by Western Blot
|
http://ncl.cancer.gov/NCL_Method_GTA-11.pdf
|
Lysosomal dysfunction is recognized as a potential toxic mechanism for xenobiotics that can...
|
xenobiotics, lysosomal pathologies, phospholipase
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |
131
|
Published Document
|
|
2011
|
Nanotechnology Characterization Laboratory
|
NCL
|
GTA-12
|
Autophagic Dysfunction in LLC-PK1 Cells
|
http://ncl.cancer.gov/NCL_Method_GTA-12.pdf
|
Lysosomal dysfunction is recognized as a potential toxic mechanism for xenobiotics that can...
|
lysosomes, phospholipase
|
e. Specification
|
Measurement and Characterizations
Health, Safety, and Environment
|
Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
|
|
|
|
|
|
Admin
|
SCulley@ansi.org
|
ANSI
|
|
http://ncl.cancer.gov/working_assay-cascade_dow...
|
EF
|
sculley
|
Editors
|
2014-07-16 |